A 27-year-old skydiving instructor in Colorado who died from an antibiotic-resistant Enterobacter aerogenes infection.
"The tragic, unnecessary, and lasting impact of the loss of our son continues to this day. Our family has never recovered from Josh's death."
A healthy 12-year
old athlete from Southern California who died of pneumonia caused by an MRSA
"A disease I had never heard of was killing my child. For
two weeks we watched Carlos deteriorate before our eyes, praying for a miracle
with every X-ray taken of his lungs."
An active, sports-driven
9-year-old boy survives a terrifying invasive infection and pneumonia caused by
"Everything the doctors said to me seemed to be preparing me
for the worst. Brock underwent five invasive surgeries, on his shoulder and in
A healthy 11-year-old girl from Tuscon,
Ariz., who spent months in the hospital fighting several antibiotic-resistant
infections and needed a lung transplant to save her life.
walked into the hospital with me on May 19, 2011, and would not pass again
through those doors until October, five months later."
Because of antibiotic resistance, many bacterial infections have become impossible to treat. New antibiotics are desperately needed to save patients' lives, but few new drugs are in pharmaceutical companies' research and development (R&D) pipelines. Low returns on investments and an unpredictable and often infeasible approval pathway at the U.S. Food and Drug Administration (FDA) have caused many companies to leave the antibiotics market.
IDSA is working to counter this decline through the 10 x '20 Initiative (read our statement). The initiative seeks a global commitment to create an antibiotic R&D enterprise powerful enough to produce 10 new systemic antibiotics by the year 2020. This effort has the potential to save thousands of lives each year. To achieve our goal, IDSA is working with a broad range of stakeholders in the United States and globally. We need your help!
Join other medical
societies, public health organizations, and universities in endorsing the 10 x
'20 initiative. See
who else has joined us >>
Frontline investigated the rise of deadly drug-resistant bacteria, watch here >>
If you or a loved
one have been devastated by an antibiotic resistant bacterial infection and you
would like to share
your story, please contact Diana
Spread the word
In May, the House of Representatives launched its 21st
Century Cures Initiative aimed at engaging stakeholders to develop policies
that will help bring new drugs to market. In response to a request for input,
IDSA highlighted the need for new incentives and regulatory changes to spur
R&D for new antibiotics and rapid diagnostics as well as public health
interventions to slow the rise of resistance.
Gonorrhea Among Drug-Resisting Germs Sickening Millions -
Sep 17, 2013
Antibiotic-Resistant Infections Lead to 23,000 Deaths a Year, CDC Finds -
Sep 16, 2013
Superbug Poses Danger in Hospitals -
Jul 05, 2013
Bugs Without Borders: The Global Challenge of MDROs -
Feb 08, 2013
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2014 Infectious Diseases Society of America